Management of low malignant potential ovarian tumors

  • W. R. Robinson


The recognition of low malignant potential (LMP) or borderline ovarian tumors as a distinct pathological entity by the International Federation of Gynecology and Obstetrics was an attempt to add a needed degree of precision to the diagnosis of ovarian tumors [1]. Despite this widely accepted improvement in histological diagnostic criteria, the behavior and prognosis of LMP tumors remain unpredictable and the appropriate treatment continues to be debated. The uncertainty in therapeutic decision making is complicated by several factors. The diagnosis of an LMP tumor is rarely made preoperatively, so the initial treatment plan is often made in the operating room by physicians unaccustomed to treating ovarian malignancies. Consultation with clinicians more experienced with these tumors is frequently not feasible. In addition, histological diagnosis by rapid frozen section of LMP tumors is often difficult and unreliable. Finally, the postoperative treatment of LMP tumors in the United States has been characterized by a wide variety of regimens, making comparisons of long term outcomes difficult.


Surgical Staging Adnexal Mass Gynecologic Oncology Group Borderline Ovarian Tumor Malignant Ovarian Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Santesson, L. and Kottmeier, H.L. (1978) General classification of ovarian tumors. In Ovarian Cancer, Vol. II, (eds F. Gentil and A.C. Sunquierra), Springer-Verlag, New York, pp. 1–8.Google Scholar
  2. 2.
    Colgan, T.J. and Norris, H.J. (1983) Ovarian epithelial tumors of low malignant potential: a review. Int. J. Gynecol Pathol., 1, 367–82.PubMedCrossRefGoogle Scholar
  3. 3.
    Merino, M. and Jaffe, G. (1993) Age contrast in ovarian pathology. Cancer, 71,537–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Creasman, W.T., Park, R., Norris, H. et al, (1982) Stage I borderline ovarian tumors. Obstet. Gynecol., 59, 93–6.PubMedGoogle Scholar
  5. 5.
    Chambers, S.T., Merino, M.S., Kohorn, E.L., et al, (1988) Borderline ovarian tumors. Am. J. Obstet. Gynecol., 159,1088–94.PubMedGoogle Scholar
  6. 6.
    Bell, D.A. and Scully, R.E. (1990) Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum. Path., 21, 397–403.PubMedCrossRefGoogle Scholar
  7. 7.
    Katsube, Y., Berg, J.W. and Silverberg, S.G. (1982) Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical area, 1 July-31 December 1969 and 1 July-31Google Scholar
  8. 8.
    Massad, L.S., Hunter, V.J., Szpak, C.A. et al., (1991) Epithelial ovarian tumors of low malignant potential. Obstet. Gynecol., 78,1027–32.PubMedGoogle Scholar
  9. 9.
    Lim-Tan, S.K., Cajigas, H.E. and Scully, R.E. (1988) Ovarian cystectomy for serous borderline tumors: a follow up study of 35 cases. Obstet. Gynecol., 72, 775–80.PubMedGoogle Scholar
  10. 10.
    Yazigi, R., Sanstad, J. and Munoz, A.K. (1988) Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol., 31,402–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Robinson, W.R., Curtin, J.P. and Morrow, C.P. (1992) Operative staging and conservative surgery in the management of low malignant potential ovarian tumors. Int. J. Gynecol Cancer, 2,113–18.PubMedCrossRefGoogle Scholar
  12. 12.
    Russell, P. (1979) The pathological assessment of ovarian neoplasms. I. Introduction to the common epithelial tumors and analysis of benign epithelial tumors. Pathology, 11, 5–26.PubMedCrossRefGoogle Scholar
  13. 13.
    Buy, J.N., Ghossain, M.A., Sciot, L. et al, (1991) Epithelial tumors of the ovary: CT findings and correlation with ultrasound. Radiology, 178, 811–18.PubMedGoogle Scholar
  14. 14.
    Granberg, S., Wikland, M. and Jansson, I. (1989) Macroscopic characterization of ovarian tumors and the relation to the histologic diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol., 35,139–44.PubMedCrossRefGoogle Scholar
  15. 15.
    Bourne, T., Campbell, S., Steer, C. et al, (1989) Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer. Br. Med J., 299,1367–70.CrossRefGoogle Scholar
  16. 16.
    Kurjak, A., Zalud, I., Surkovic, D. et al, (1989) Transvaginal color Doppler for the assessment of pelvic circulation. Acta Obstet. Gynecol Scand., 68,131–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Fleischer, A.C., Rodgers, W.H., Bhaskara, K.R. et al, (1991) Assessment of ovarian tumor vascularity with transvaginal colour Doppler sonography. J. Ultrasound. Med., 10, 563–8.PubMedGoogle Scholar
  18. 18.
    Finkler, N.G., Benacerraf, B., Lavin, R.T. et al, (1988) Comparison of serum Ca-125, cHnical impression, and ultrasound in the preoperative evaluation of ovarian masses. Obstet. Gynecol., 72, 659–64.PubMedGoogle Scholar
  19. 19.
    Mogensen, O., Mogensen, B., Jakobsen, A. and Sell, A. (1989) Preoperative measurement of cancer antigen 125 (CA-125) in the differential diagnosis of ovarian tumors. Acta Oncol., 28, 471–3.PubMedCrossRefGoogle Scholar
  20. 20.
    Rice, L.W., Berkowitz, R.S., Mark, S.D. et al, (1990) Epithehal ovarian tumors of borderline mahgnancy. Gynecol. Oncol., 39,195–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Tholander, B., Taube, A., Lindgren, A. et al, (1990) Pretreatment serum levels of CA-125, carcino embryonic antigen, tissue polypeptide antigen and placental alkaline phosphatase in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis. Gynecol Oncol., 39, 16–25.PubMedCrossRefGoogle Scholar
  22. 22.
    Tasker, M. and Langley, F.A. (1985) The outlook for women with borderline epithelial tumors of the ovary. Br. J Obstet. Gynecol., 92, 969–73.CrossRefGoogle Scholar
  23. 23.
    Navot, D., Fox, J.H., Williams, M. et al, (1991) The concept of uterine preservation with ovarian malignancies. Obstet. Gynecol., 78, 566–8.PubMedGoogle Scholar
  24. 24.
    Andrieu, S.M. and Ochoa-Molina, M.E. (1983) Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkins disease. Cancer, 52,435.PubMedCrossRefGoogle Scholar
  25. 25.
    Bakri, Y.N. and Given, F.T. (1984) Normal pregnancy and deUvery following conservative surgery and chemotherapy for ovarian endodermal sinus tumor. Gynecol Oncol., 16, 414.Google Scholar
  26. 26.
    Baak, S.P., Langley, F.A., Talerman, A. et al, (1987) The prognostic variability of ovarian tumor grading by different pathologists. Gynecol Oncol., 27,166–72.PubMedCrossRefGoogle Scholar
  27. 27.
    Stalsberg, T.I., Abeler, V., Blom, G.P. et al, (1988) Observer variation in histologic classification of malignant and borderline ovarian tumors. Hum. Pathol., 19,1030–5.PubMedCrossRefGoogle Scholar
  28. 28.
    TwaalFhoven, F.A.C., Peters, A.A.W. and Trimbas, S.B. (1991) The accuracy of frozen section diagnosis of ovarian tumors. Gynecol Oncol,., 41,189–92.CrossRefGoogle Scholar
  29. 29.
    Snider, D.D., Stuart, G.C., Nation, J.G. et al, (1991) Evaluation of surgical staging in stage I low malignant potential ovarian tumors. Gynecol Oncol., 40,129–32.PubMedCrossRefGoogle Scholar
  30. 30.
    Nation, J.G. and Krepart, G.V. (1986) Ovarian carcinoma at low malignant potential: staging and treatment. Am. J. Obstet. Gynecol., 154, 290–3.PubMedGoogle Scholar
  31. 31.
    Leake, J.F., Rader, R.S., Woodruff, J.D. et al, (1991) Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malig-41. nant potential. Gynecol Oncol., 42,124–30.PubMedCrossRefGoogle Scholar
  32. 32.
    Nezhat, C., Nezhat, F. and Burrell, M. (1992) Laparoscopically assisted hysterectomy for the management of a borderline ovarian tumor: a case report, J. Laparoendosc. Surg., 2,167–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Cristali, B., Cayol, A., Izard, V. et al, (1992) Benefit of operative laparoscopy for ovarian tumors suspected of benignity, J. Laparendosc., Surg., 2,69–73.CrossRefGoogle Scholar
  34. 34.
    Dembo, A.J., Davy, M., Stenwig, A.E. et al, (1990) Prognostic factors in patients with stage I epithelial ovarian cancer.Obstet. Gynecol., 75, 263–73.PubMedGoogle Scholar
  35. 35.
    Sevelda, P., Dittrich, C. and Salzer, H. (1989) Prognostic value of the rupture of the capsule in stage I epithelial ovarian carcinoma. Gynecol Oncol., 35, 321–2.PubMedCrossRefGoogle Scholar
  36. 36.
    Michael, H. and Roth, L.M. (1986) Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer, 53,1240–7.CrossRefGoogle Scholar
  37. 37.
    Gershenson, D.M. and Silva, E.G. (1990) Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer, 65, 578–85.PubMedCrossRefGoogle Scholar
  38. 38.
    Katzenstein, A.A., Mazur, M.T., Morgan, T.E. et al, (1978) Proliferative serous tumors of the ovary. Histologic features and prognosis. Am. J. Surg. Pathol, 2,339–55.PubMedCrossRefGoogle Scholar
  39. 39.
    Russell, P. and Merkur, H. (1979) Proliferating ovarian epithelial tumours: a clinical pathological analysis of 144 cases. Aust. NZ J. Obstet. Gynecol, 19, 45–51.CrossRefGoogle Scholar
  40. 40.
    Leake, J.F., Currie, S.L., Rosenshein, N.B. et al, (1992) Long term follow-up of serous ovarian tumors of low malignant potential. Gynecol, Oncol., 47,150–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Chien, R., Rehenmaier, M.A., Micha, J.P. et al, (1989) Ovarian epithelial tumors of low malignant potential. Surg. Gynecol Obstet., 169, 143–6.PubMedGoogle Scholar
  42. 42.
    Fort, G.M., Pierce, V.K., Scigo, P.E. et al, (1989) Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol., 32,269–72.PubMedCrossRefGoogle Scholar
  43. 43.
    Yazig, R., Munoz, A.K., Sandstad, J. et al, (1991) Cisplatin based combination chemotherapy in the treatment of stage III ovarian epithelial tumors of low malignant potential. Eur. J. Gynec. Oncol., 6,451–5.Google Scholar
  44. 44.
    Sutton, G.P., Bundy, B.N., Omura, G.A. et al, (1991) Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study). Gynecol Oncol., 41,230–3.PubMedCrossRefGoogle Scholar
  45. 45.
    O’Quinn, A.G. and Hannigan, E.V. (1985) Epithelial ovarian neoplasms of low malignant potential. Gynecol Oncol., 21,177–83.PubMedCrossRefGoogle Scholar
  46. 46.
    Russell, P. (1984) Borderline epithelial tumors of the ovary: a conceptual dilemma. Clin. Obstet. Gynecol., 11,259–76.Google Scholar
  47. 47.
    McCaughey, W.T.E., Kirk, M.E., Lester, W. et al, (1984) Peritoneal epithelial lesions associated with proliferative serous tumors of the ovary. Histopathology, 8,195–208.PubMedCrossRefGoogle Scholar
  48. 48.
    Hopkins, M.P. and Morley, G.W. (1989) The second look operation and surgical staging in ovarian tumor of low malignant potential. Obstet. Gynecol., 74, 375–8.PubMedGoogle Scholar
  49. 49.
    Barnhill, D.R., O’Connor, D.M. (1991) Management of ovarian neoplasms of low malignant potential. Oncology, 5, 21–32.PubMedGoogle Scholar
  50. 50.
    Leake, S.F. (1992) Tumors of low malignant potential. Curr. Opin. Obstet. Gynecol., 4, 81–5.PubMedGoogle Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • W. R. Robinson

There are no affiliations available

Personalised recommendations